1Q FY2018 (Fiscal Year Ending March 31, 2019) Financial Results. Copyright Sogo Medical Co., Ltd. All Rights Reserved.

Size: px
Start display at page:

Download "1Q FY2018 (Fiscal Year Ending March 31, 2019) Financial Results. Copyright Sogo Medical Co., Ltd. All Rights Reserved."

Transcription

1 (Fiscal Year Ending March 31, 2019) Financial Results

2 Contents 1. Summary of Financial Results and Forecast 2 Consolidated Earnings 3 Profit & Losses (by Business Segment) 4 Medical Practice Support Data (Consulting) 5 Medical Practice Support Data (Rental, Leasing & Installment) 6 Pharmacy Data (Sales & Number of Pharmacies) 7 Pharmacy Data (Prescriptions & Unit Price) 8 Trends for Major Items in the Basic Dispensing Fee and Technical Fee Components 9 Financial Position (Balance Sheets) 10 FY2018 Financial Forecast Measures Undertaken in 12 Healthcare Mall Development 13 Hospital Management Support 14 Creation of High-value Pharmacies 15 Measures Carried Out by Bunkyo Corporation Appendix 17 Quarterly Earnings Trends (by Business) 18 Quarterly Earnings Trends (Data Summary) 19 Medical Practice Support Data 20 Pharmacy Data 21 Explanation of the appropriate use of financial result forecasts. These financial result forecasts are based on currently available information. Actual financial results could differ from these forecasts due to various factors. ( The amounts are rounded down. ) Copyright Sogo Medical Co., Ltd All Rights Reserved. 1

3 1 Copyright Summary of Q1 FY2018 Financial Results and Forecast Sogo Medical Co., Ltd. All Rights Reserved.

4 Consolidated Earnings ( million) Sales (left axis) Ordinary income (right axis) ( million) 2,000 40,000 30,000 20,000 10,000 33,191 1,332 35, ,500 1, Net sales Operating income Ordinary income Quarterly Profit attributable to owners of parent 1Q FY2017 result result YoY YoY (%) (\million) Achieveme Achievement nt rate for rate for 1H FY2018 plan plan 33,191 35,155 1, % 50.6% 24.3% (100.0%) (100.0%) 1, % 36.8% 14.4% (4.2%) (2.4%) 1, % 39.6% 14.9% (4.0%) (2.5%) % 33.5% 12.6% (2.4%) (1.2%) 0 1Q FY Quarterly net income per share ( ) % - - *On April 1, 2018, Sogo Medical implemented a 2:1 common stock split. Net income per share prior to this date was calculated based on the assumption this stock split had been carried out. *The figures in parentheses represent the ratio to total sales. Copyright Sogo Medical Co., Ltd All Rights Reserved. 3

5 Profit & Losses (by Business Segment) 1Q FY2017 result result YoY YoY (%) Net sales 33,191 35,155 1, % Main factors (\million) Medical practice support 6,092 8,936 2, % Consulting +91, doctor job transfers and private practice start-up Consulting % support +5 Rental 1,539 2, % Rental +321, sales of subrental +185 Leasing/installment +53, sales of sublease -57, Leasing/Installment 2,334 2, % merchandise sales -98 Others 1,729 4,072 2,342 In-hospital store sales, etc. +2,426, design and construction -238, 135.5% medical professional referral and dispatch +73 Pharmacies 26,853 25, Existing pharmacy sales -1,242, pharmacies opened in FY % +404, pharmacies opening FY , pharmacy closures, etc Others % Operating income 1, % Medical practice support % Consulting +39, rental +28, in-hospital store sales, etc. +37 Pharmacies 1, % Profit decline in tandem with sales drop Others % Elimination & Corporate (87) (63) 24 - Copyright Sogo Medical Co., Ltd All Rights Reserved. 4

6 Medical Practice Support Data (Consulting) ( million) DtoD concierge ad revenue Start-up support, etc. Transfer support Consulting Start-up support Support of medical practices carried on by successors 1Q FY2017 result result YoY Total for transfer support 1,349 1, Full-time Part-time 1,344 1, Q FY2017 March 31, June 30, YoY Doctors registered for DtoD (No. of people) 74,898 76,028 1,130 Succeed Members (cases) 1,680 1,687 7 Copyright Sogo Medical Co., Ltd All Rights Reserved. 5

7 Medical Practice Support Data (Rental, Leasing & Installment) ( million) Sales of subrental Rental 2,045 1,539 1,487 1, Q FY2017 Number of rental TVs in operation (TVs) June 30, June 30, YoY YoY (%) 145, ,649 8, % ( million) 3,000 2,500 2,000 1,500 1, Sales of sublease Merchandise sales Leasing/installment 2,334 2, ,683 1,626 1Q FY2017 Leasing/installment volume 1Q FY2017 result result YoY YoY (%) 1,901 2, % Copyright Sogo Medical Co., Ltd All Rights Reserved. 6

8 Pharmacy Data (Sales & Number of Pharmacies) FY2017 result ( million) 27,000 25,000 <Dispensing sales> Openings/closing in FY2018 Openings in FY2017 Existing pharmacies 26, <OTC sales, etc.> Sales of OTCs, etc. 25, Number of pharmacies Number of new openings Start-up support portion Existing pharmacy portion M&A portion Number of closings , ,106 1Q FY ,864 ( million) 5,000 4,500 4,000 3,500 3,000 Sales (all pharmacies) Sales (existing pharmacies) *1 Prescription volume (all pharmacies) Prescription volume (existing pharmacies) *1 3, (+13.7%) (+4.6%) 1Q FY2017 4,355 3,879 *2 (+12.3%) 3,933 (+1.4%)*2 (in thousands) Copyright Sogo Medical Co., Ltd All Rights Reserved *1 Existing pharmacies = 76 pharmacies opened in healthcare malls as of the end of 1Q FY2017 *2 The figures in parentheses are comparison with 1Q FY2017 *2 *2 0

9 Pharmacy Data (Prescriptions & Unit Price) All pharmacies (in thousands) 3,100 Existing pharmacies *2 3,067 ( ) 12,000 Dispensing fee unit price Prescription unit price Dispensing fee unit price 3,050 3,000 2,950 2,900 2,996 *1 *1 *1 2,996 2,994 10,000 8,000 6,000 4,000 2,000 8,762 8,292 6,467 6,065 2,295 2, Q FY Q FY2017 Average Average 1Q FY2017 result result YoY YoY (%) 1Q FY2017 Average Average YoY YoY (%) All pharmacies 2,996 * 1 3,067 * % Prescription unit price 8,762 8, % Existing pharmacies 2,996 *1 2,994 * % Dispensing fee unit price 6,467 6, % Technical fee unit price 2,295 2, % *1: 672 pharmacies677 店舗ー閉局 5 店舗 ) *2: 691 pharmacies * Prescription unit price = Dispensing fee unit price + Technical fee unit price Copyright Sogo Medical Co., Ltd All Rights Reserved. 8

10 Trends for Major Items in the Basic Dispensing Fee and Technical Fee Components (pharmacies) /03 No regional support program premium (0 points) Regional support program premium (32 points) / / /06 *Basic dispensing fee premium in FY2017 Premium 3 (26 points) Premium 1 (18 points) 450 Premium 2 (22 points) No premium (0 points) (cases) 80,000 70,000 60,000 50,000 40,000 30,000 20,000 (%) Guidance fee premium owing to number of primary pharmacists (left axis) Number of primary pharmacist consent forms received (left axis) Number of primary pharmacists (right axis) (No. of people) ,959 54,563 56,371 40,044 41,614 38,760 Number of pharmacies with a concentration ratio of less than 85% (right axis) 集中率 Concentration ( 左軸 ) ratio 集中率 (left axis) 85% 未満の店舗数 ( 右軸 ) / / /06 Concentration ratio (left axis) Number of pharmacies with a concentration ratio of less than 85% (right axis) , (Pharmacies) / / / / /06 *Standalone data for Sogo Medical Copyright Sogo Medical Co., Ltd All Rights Reserved. 9

11 Financial Position (Balance Sheets) FY2017 June 31, 2018 YoY Total assets 89,748 89, Current assets 47,485 44,225-3,259 (Cash and deposits) 14,538 13, Acquisition of equity in Bunkyo -3,575 Decrease in dispensing fee receivables and sales of (Notes and accounts receivable-trade) 20,536 18,039-2,496 sublease receivables (Inventories) 5,787 6, Noncurrent assets 42,263 45,717 3,453 (Property, plant and equipment) 25,440 26, (Intangible assets) 10,502 13,021 2,518 Goodwill +2,549 (Bunkyo portion +2,784) Total liabilities 53,221 53, Decrease in sales of sublease receivables Current liabilities 33,598 31,950-1,647 (Notes and accounts payable-trade) 20,037 18,567-1,470 (Current portion of long-term loans payable) 4,429 4, Noncurrent liabilities 19,623 21,496 1,873 (Long-term loans payable) 13,831 14,904 1,073 (Long-term accounts payable-installment purchase) 2,754 3, (Interest-bearing debts) 23,529 25,829 2,299 Total net assets 36,526 36, Net income +430, dividend payments -486 Total liabilities and net assets 89,748 89, Net assets per share (\) *1 1, , Capital adequacy ratio (%) Net D/E ratio (times) * Main sources of changes (\million) *1: On April 1, 2018, Sogo Medical implemented a 2:1 common stock split. Net income per share prior to this date was calculated based on the assumption this stock split had been carried out. *2: Net D/E ratio = Net interest-bearing liabilities (interest-bearing liabilities cash and deposits) / shareholders equity + interest-bearing debt; this includes the leasing receivables and installment receivables posted to the balance sheet Copyright Sogo Medical Co., Ltd All Rights Reserved. 10

12 FY2018 Financial Forecast (\million) FY2017 FY2018 YoY 1Q 1H Full year 1Q results 1Q plan achieveme nt rate 2Q 1H Full-year estimate* forecast forecast Change 1H Full year Change Change Change (%) (%) Net sales 66, ,431 35,155 33, % 34,379 69, ,928 3, % 9, % Medical practice support 12,627 24,548 8,936 7, % , , % Pharmacies 53, ,918 25,977 25, % , , % Others % - - 1, % Gross profit 9,729 20,354 5,154 4, % 5,316 10,470 22, % 2, % SG&A 6,628 13,164 4,321 4, % 3,886 8,207 16,995 1, % 3, % Operating income 3,101 7, % 1,431 2,263 5, % -1, % Ordinary income 3,118 7, % 1,322 2,188 5, % -1, % Profit attributable to owners of parent 1,839 4, % 854 1,284 3, % % Net income per share ( ) * 2Q estimate = 1H forecast 1Q results * On April 1, 2018, Sogo Medical implemented a 2:1 common stock split. Net income per share prior to this date was calculated based on the assumption this stock split had been carried out. Copyright Sogo Medical Co., Ltd All Rights Reserved. 11

13 2 Measures Undertaken in

14 Healthcare Mall Development Opened May 2018 in Hirakata, Osaka Number of healthcare mall projects 184 Target projects Key projects 47 Finalized projects Track record Support Start-up consulting Design and construction Leasing Risk assessment March 31,2018 Hirakata, Osaka Saitama, Saitama Pref. Copyright Sogo Medical Co., Ltd All Rights Reserved

15 Hospital Management Support Hiroshima Prefecture 9 10 Support Consulting (operations contracts) Construction of facilityʼs interior Leasing/installment Rental Risk assessment Facility leasing Pharmacy Departments Internal Medicine, Pediatrics, Surgical, Proctology,Orthopedics, Dialysis FY Q FY Copyright Sogo Medical Co., Ltd All Rights Reserved

16 Creation of High-value Pharmacies In Fukuoka, 4 Sogo Medical Pharmacies were licensed by the city as a business to provide remote guidance on how to properly take medications by using the National Strategic Special Zones Law in Fukuoka City. Through this initiative, the Sogo Medical Group aims to build a home medical care service system, strengthen the function of pharmacies and pharmacists, and improve convenience for service users. In addition, this provides a new value for environment and medical services whereby users can remain in their homes, which they are used to living in and where they feel safe and secure. * 91% 79% Deploy at-home medical care services nationwide Share knowhow within the group and undertake home healthcare nationwide Cancer 11pharmacists * pharmacists Diabetes 19pharmacists * pharmacists Home care 13pharmacists pharmacists * Train pharmacists to have an area of specialization Improve care by training pharmacists to have advanced expertise to address local needs For this remote guidance for taking medications, Sogo Medical plans to utilize a system developed by Minacolor Inc. and an integrated model offering by Mitsui & Co., Ltd. which facilitates online medical exams, online guidance by a pharmacist, and the delivery of medications. Doctor Clinic 39pharmacies 92pharmacies Pharmacists that have completed healthcare support pharmacy training * * 213pharmacists 58,203 cases* 91,299cases 715pharmacists Patients 5Medication delivery 2 Issue prescription Pharmacists Pharmacy Image of the remote guidance for taking medications using an integrated model Actively support the development Central management using a of health of local residents smartphone of an individual s Of the 1,003 pharmacies nationwide medication history and information that have submitted applications, on their health roughly 9% of total are Centralized management of medication history our group pharmacies Share information to provide more accurate guidance *Current as of June 30, 2017 Copyright Sogo Medical Co., Ltd All Rights Reserved. 15

17 Measures Carried Out by Bunkyo Corporation Joint project for rental services at 4 facilities, total of 2,000 beds currently being proposed Cross-sell of both companiesʼ services Sogo Medical existing area Sogo Medical new target Bunkyo existing area Bunkyo new target Existing area Kanto Chukyo Kyushu New areas Kinki Tohoku, etc. No. of beds Area East Japan West Japan Kyushu No. of beds Expand area leveraging Sogo Medicalʼs sales network TV rental business: Integrate purchasing and review maintenance system Reduce cost by 30% Use Sogo Medical products to fill new and replacement orders. Also use Sogo Medical s maintenance system. Integrate purchasing of merchandise of hospital shops Review purchasing cost by using same supplier and improve delivery lead time. Shops sales of Sogo Medical PB products and development of new PB products Expect to boost profit margin Sogo Medical drinks, throat lozenges, sanitary goods, etc. Copyright Sogo Medical Co., Ltd All Rights Reserved. 16

18 3 Appendix

19 Quarterly Earnings Trends (by Business) (\million) FY2016 FY2017 FY2018 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q Sales 28,102 29,217 29,388 35,507 33,191 33,300 33,730 35,210 35,155 Medical practice support 5,179 6,383 5,412 8,329 6,092 6,535 5,404 6,517 8,936 Consulting Rental 1,492 1,851 1,391 2,100 1,539 1,759 1,157 1,221 2,045 Leasing/installment 2,280 2,399 1,911 3,562 2,334 2,603 2,016 2,747 2,231 Others 945 1,632 1,661 2,041 1,729 1,622 1,703 1,869 4,072 Pharmacies Others Cost of sales Gross profit SG&A Operating income Ordinary income Quarterly profit attributable to owners of parent 22,699 22,599 23,738 26,929 26,853 26,536 28,086 28,443 25, ,026 24,969 24,746 30,019 28,492 28,270 28,675 29,640 30,001 4,076 4,247 4,641 5,488 4,699 5,030 5,055 5,570 5,154 2,951 2,940 2,964 3,350 3,312 3,316 3,215 3,321 4,321 1,125 1,307 1,677 2,137 1,387 1,714 1,839 2, ,101 1,311 1,723 2,303 1,332 1,786 1,842 2, , ,032 1,113 1, Copyright Sogo Medical Co., Ltd All Rights Reserved. 18

20 Quarterly Earnings Trends (Data Summary) (\million) FY2016 FY2017 FY2018 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q Consulting sales Consulting Practice transfer/start-up support Practice transfer support Practice start-up support DtoD-concierge advertising No. of new doctor registrations for DtoD (people) (Number of doctors wishing to transfer/start-up a 1,933 1,281 1,800 1,716 1,312 1,796 1,563 1,068 1,130 practice using the DtoD System) Practice transfer support (cases) 1,348 1,220 1,378 1,237 1,349 1,135 1,322 1,157 1,168 Full time Part time 1,340 1,204 1,371 1,202 1,344 1,124 1,318 1,127 1,165 Support of medical practices carried on by successors Rental sales 1,492 1,851 1,391 2,100 1,539 1,759 1,157 1,221 2,045 Sales of subrental Rental 1,178 1,263 1,175 1,214 1,166 1,214 1,157 1,221 1,487 Leasing sales 2,280 2,399 1,911 3,562 2,334 2,603 2,016 2,747 2,231 Sales of sublease 1,764 1,911 1,389 2,709 1,683 1,985 1,528 1,946 1,626 Leasing / Installment Sales of medical equipment Dispensing pharmacies (Pharmacies)* New open Number of prescriptions (thousands) 2,544 2,508 2,712 3,050 3,010 2,929 3,135 3,202 3,067 Healthcare malls* Number of management support cases* *Total for the end of the fiscal year Copyright Sogo Medical Co., Ltd All Rights Reserved. 19

21 Medical Practice Support Data FY2015 FY2016 FY2017 FY2015 FY2016 FY2017 Total Consulting Practice transfer/start-up support 1,894 2,035 2,247 1,232 1,483 1, Practice transfer support Practice start-up support DtoD-concierge advertising Total 5,465 6,836 5,676 Sales of subrental 800 2, Rentals 4,665 4,832 4,758 Support of medical practices carried on by successors Practice transfer support Full time Part time FY2015 FY2016 FY ,863 5,183 4, ,773 5,117 4,913 FY2015 FY2016 FY2017 Total 11,035 10,153 9,700 Sales of sublease 8,690 7,774 7,142 Leasing/installment 1,421 1,308 1,215 Goods 923 1,070 1,342 FY2015 FY2016 FY2017 DtoD registered doctors Succeed Members 62,429 69,159 74,898 1,639 1,666 1,680 Copyright Sogo Medical Co., Ltd All Rights Reserved. 20

22 Pharmacy Data FY2015 FY2016 FY2017 FY2015 FY2016 FY2017 Pharmacies 96,405 95, ,918 Dispensing sales 95,119 94, ,919 Existing pharmacies 93,804 89,784 92,292 Pharmacies opened in FY2017-3,755 14,113 Pharmacies opened/closed in FY ,513 OTC sales 1,285 1,499 1,998 No. of pharmacies No. of newly opened pharmacies Start-up support client portion Existing client portion M&A portion No. of pharmacies closed FY2015 FY2016 FY2017 Prescriptions (1,000) Unit price ( ) Prescriptions (1,000) Unit price ( ) Prescriptions (1,000) Unit price ( ) All pharmacies 10,039 9,474 10,814 8,735 12,276 8,790 Existing pharmacies 9,930 9,446 10,265 8,746 10,361 8,906 Copyright Sogo Medical Co., Ltd All Rights Reserved. 21

23

24

25

26

27 ( Securities code: 4775 ) Contact SOGO MEDICAL CO., LTD Public Information and Investor Relations Division Tel: Fax: ir@sogo-medical.co.jp These presentation materials have been released on the following web page: URL : Copyright Sogo Medical Co., Ltd All Rights Reserved. 26

Summary of Consolidated Financial Results for the Three-Month Period ended June 30, 2018 Japanese GAAP July 24, 2018

Summary of Consolidated Financial Results for the Three-Month Period ended June 30, 2018 Japanese GAAP July 24, 2018 for the Three-Month Period ended June 30, 2018 Japanese GAAP July 24, 2018 Company name: SOGO MEDICAL CO., LTD. Stock exchange listings: Tokyo 1st Section Securities code: 4775 URL: https://www.sogo-medical.co.jp/english/

More information

Summary of Consolidated Financial Results for the Nine -Month Period ended December 31, 2015 Japanese GAAP

Summary of Consolidated Financial Results for the Nine -Month Period ended December 31, 2015 Japanese GAAP This summary is a translation of KESSAN TANSHIN which is an unaudited report. for the Nine -Month Period ended December 31, 2015 Japanese GAAP January 21, 2016 Company name: SOGO MEDICAL CO., LTD. Stock

More information

FY4/18 IR PRESENTATION

FY4/18 IR PRESENTATION IR PRESENTATION June 2018 Results Overview 1 Consolidated P/L Net sales increased 8.2% year on year and 0.3% against the plan due to business growth in same stores and stores that were opened in previous

More information

We encourage readers to review our complete legal statement on Disclaimer page.

We encourage readers to review our complete legal statement on Disclaimer page. Company Research and Analysis Report FISCO Ltd. http://www.fisco.co.jp 伪伪 Targeting consolidated net sales of 300bn in 10 years time by a Group expansion strategy that employs M&A (hereafter, also

More information

Results of Operations

Results of Operations Results of Operations for the Fiscal Year Ended August 2017 (FY8/17) October 20, 2017 Contents Corporate Overview 3 Organization 4 FY8/17 Consolidated Results of Operations 5 Financial Highlights 6 Consolidated

More information

Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April [Japan GAAP] (Consolidated)

Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April [Japan GAAP] (Consolidated) Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April 2018 Name of listed company: Exchange listed on: AIN HOLDINGS INC. [Japan GAAP] (Consolidated) First Section of Tokyo

More information

Positioned to Succeed ANNUAL REPORT 2016

Positioned to Succeed ANNUAL REPORT 2016 Positioned to Succeed ANNUAL REPORT 2016 For the year ended April 30, 2016 Profile Message from the President AIN HOLDINGS has grown by consistently staying ahead of change Aiming to increase corporate

More information

Summary of Financial Statements for the Third Quarter of Fiscal Year Ending April [Japan GAAP] (Consolidated)

Summary of Financial Statements for the Third Quarter of Fiscal Year Ending April [Japan GAAP] (Consolidated) Summary of Financial Statements for the Third Quarter of Fiscal Year Ending April 2019 Name of listed company: Exchange listed on: AIN HOLDINGS INC. [Japan GAAP] (Consolidated) First Section of Tokyo Stock

More information

Medical System Network 4350 Tokyo Stock Exchange First Section

Medical System Network 4350 Tokyo Stock Exchange First Section Company Research and Analysis Report FISCO Ltd. http://www.fisco.co.jp 伪伪 Aiming for greater profit growth by expanding its two main businesses: Pharmaceutical Network Business and Dispensing Pharmacy

More information

Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April [Japan GAAP] (Consolidated)

Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April [Japan GAAP] (Consolidated) Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April 2019 Name of listed company: Exchange listed on: AIN HOLDINGS INC. [Japan GAAP] (Consolidated) First Section of Tokyo

More information

Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending May 15, 2018 [J-GAAP]

Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending May 15, 2018 [J-GAAP] Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending May 15, 2018 [J-GAAP] March 13, 2018 Name of listed company: TSURUHA Holdings, Inc. Listed on: Tokyo Stock Exchange, 1st Section

More information

Summary of Reference data

Summary of Reference data Summary of Reference data Fiscal Year August 2015 (September 1, 2015 to August 31, 2016) (Tokyo Stock Exchange, 1st Section:3048) 1. Fiscal Year August 2015 2. Earnings Forecast for FY2016 3. Topics FY2016

More information

Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending May 15, 2018 [J-GAAP]

Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending May 15, 2018 [J-GAAP] Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending May 15, 2018 [J-GAAP] December 19, 2017 Name of listed company: TSURUHA Holdings, Inc. Listed on: Tokyo Stock Exchange, 1st

More information

FamilyMart UNY Holdings Co., Ltd. Fiscal 2016 Financial Review

FamilyMart UNY Holdings Co., Ltd. Fiscal 2016 Financial Review FamilyMart UNY Holdings Co., Ltd. Fiscal 2016 Financial Review April 2017 Cautionary Statement: This report contains forward-looking statements, including the Company s strategies, future business plans,

More information

Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending May 15, 2019 [J-GAAP]

Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending May 15, 2019 [J-GAAP] Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending May 15, 2019 [J-GAAP] December 18, 2018 Name of listed company: TSURUHA Holdings, Inc. Listed on: Tokyo Stock Exchange, 1st

More information

Table of Contents P 2 P 4 P 10 P 11 P 12 P 13 P 14 P 17 P 18 P 19

Table of Contents P 2 P 4 P 10 P 11 P 12 P 13 P 14 P 17 P 18 P 19 Saizeriya Co., Ltd. Financial Results Briefing Session for the Second Quarter of the Fiscal Year Ended August 31, 2014 (42th term: from September 1, 2013 to February 28, 2014) Code No. 7581 Thursday, April

More information

FY rd Quarter Presentation Material

FY rd Quarter Presentation Material FY2015 3 rd Quarter Presentation Material January 8, 2016 AEON Co., Ltd. FY 2015 3 rd Quarter: Financial Results Operating revenue for the first 9 months of the fiscal year was at a record high, with operating

More information

Summary of Financial Statements for Third Quarter of Fiscal Year Ending March 31, 2018 [Japanese GAAP] (Consolidated) February 6, 2018

Summary of Financial Statements for Third Quarter of Fiscal Year Ending March 31, 2018 [Japanese GAAP] (Consolidated) February 6, 2018 Summary of Financial Statements [Japanese GAAP] (Consolidated) February 6, 2018 Name of listed company: SHIP HEALTHCARE HOLDINGS, INC. Shares listed on: Tokyo Stock Exchange Code: 3360 URL http://www.shiphd.co.jp/

More information

Net sales Operating profit Ordinary profit

Net sales Operating profit Ordinary profit Notice: This document has been translated from Japanese original for reference purpose only, without any warranty as to its accuracy or as to the completeness of the information. The Japanese original

More information

Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018 [Japanese GAAP] (Consolidated)

Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018 [Japanese GAAP] (Consolidated) Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018 [Japanese GAAP] (Consolidated) February 13, 2018 Name of Listed Company: UCHIYAMA HOLDINGS INC. Stock Listing: TSE Code

More information

FY4/13 Results Briefing

FY4/13 Results Briefing Results Briefing June 5,2013 Results Overview 1 Consolidated P/L The Group reported net sales of 154,560 million, an increase of 8.2% year on year due to the opening of 83 stores including M&A. However,

More information

Consolidated Financial Summary for the Second Quarter Ended June 30, 2018 (Japanese Standard)

Consolidated Financial Summary for the Second Quarter Ended June 30, 2018 (Japanese Standard) This document is a summary translation of the Japanese language original version. In the event of any discrepancy, errors and/or omissions, the Japanese language version shall prevail. Consolidated Financial

More information

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending May 15, 2019 [J-GAAP]

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending May 15, 2019 [J-GAAP] Consolidated Financial Results for the First Quarter of the Fiscal Year Ending May 15, 2019 [J-GAAP] September 18, 2018 Name of listed company: TSURUHA Holdings, Inc. Listed on: Tokyo Stock Exchange, 1st

More information

FY4/14 Results Briefing

FY4/14 Results Briefing Results Briefing June 5,2014 Result Overview 1 Consolidated P/L The Group reported net sales of 170,225 million, an increase of 10.1% year on year, reflecting the opening of new dispensing pharmacies and

More information

1. Consolidated Financial Results for the Second Quarter Ended September 30, 2017 (April 1, 2017 September 30, 2017)

1. Consolidated Financial Results for the Second Quarter Ended September 30, 2017 (April 1, 2017 September 30, 2017) Notice: This document has been translated from Japanese original for reference purpose only, without any warranty as to its accuracy or as to the completeness of the information. The Japanese original

More information

November 16, 2017 Hoosiers Holdings (3284) Second-Quarter Fiscal Year Ending March 31, 2018: Supplemental Explanatory Materials for Financial Results

November 16, 2017 Hoosiers Holdings (3284) Second-Quarter Fiscal Year Ending March 31, 2018: Supplemental Explanatory Materials for Financial Results November 16, 2017 Hoosiers Holdings (3284) Second-Quarter Fiscal Year Ending March 31, 2018: Supplemental Explanatory Materials for Financial Results Agenda 1. Company information Company overview Group

More information

Consolidated Financial Report for the First Quarter of Fiscal 2014 Ending March 31, 2014 (Japanese GAAP)

Consolidated Financial Report for the First Quarter of Fiscal 2014 Ending March 31, 2014 (Japanese GAAP) Disclaimer: This is a Japanese-English translation of the summary of financial statements of the Company produced for your convenience. Since no auditor audited this report, officially only the Japanese

More information

FY4/18 2Q IR PRESENTATION

FY4/18 2Q IR PRESENTATION IR PRESENTATION December 2017 2Q Results Overview 1 Consolidated P/L Net sales increased 13.3% year on year and 2.3% against the plan due to firm growth in same stores and stores that were opened in previous

More information

Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2010

Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2010 February 5, 2010 Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2010 NIHON KOHDEN CORPORATION (6849) Stock Exchange Listing: Head Office: Representative: Contact:

More information

Summary of Financial Statements for Second Quarter of Fiscal Year Ending March 31, 2019 [Japanese GAAP] (Consolidated) November 9, 2018

Summary of Financial Statements for Second Quarter of Fiscal Year Ending March 31, 2019 [Japanese GAAP] (Consolidated) November 9, 2018 Summary of Financial Statements [Japanese GAAP] (Consolidated) November 9, 2018 Name of listed company: SHIP HEALTHCARE HOLDINGS, INC. Shares listed on: Tokyo Stock Exchange Code: 3360 URL http://www.shiphd.co.jp/

More information

IR PRESENTATION June 2015

IR PRESENTATION June 2015 IR PRESENTATION June 2015 Results Overview 1 Consolidated P/L For the fiscal year under the review, the Group reported net sales of 187,904 million, an increase of 10.4% year on year, reflecting the opening

More information

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results (Note) This translation is prepared and provided for readers' convenience only. In the event of any discrepancy between this translated document and the original Japanese document, the original document

More information

We encourage readers to review our complete legal statement on Disclaimer page.

We encourage readers to review our complete legal statement on Disclaimer page. Company Research and Analysis Report FISCO Ltd. http://www.fisco.co.jp 伪伪 Absorbing the impact of revisions to dispensing fees and continuing to increase sales and profits Nihon Chouzai Co., Ltd.

More information

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results (Note) This translation is prepared and provided for readers' convenience only. In the event of any discrepancy between this translated document and the original Japanese document, the original document

More information

Summary Report of Consolidated Financial Results

Summary Report of Consolidated Financial Results Summary Report of Consolidated Financial Results for the third quarter ended September 30, 2012 October 23,2012 Registered company name: Canon Marketing Japan Inc. Stock listing: Tokyo Stock Exchange,

More information

Operating Income. Change (%) Change (%) Fiscal year ended June 30, 2015

Operating Income. Change (%) Change (%) Fiscal year ended June 30, 2015 Summary Report of Consolidated Financial Results For the Fiscal Year Ended (All financial information has been prepared in accordance with accounting principles generally accepted in Japan.) Don Quijote

More information

FY2018 2Q CONSOLIDATED BUSINESS RESULTS

FY2018 2Q CONSOLIDATED BUSINESS RESULTS FY218 2Q CONSOLIDATED BUSINESS RESULTS FY218 2Q HIGHLIGHTS 1 Overview Gross Merchandise Value : 141,221 million yen ( + 18.%,Yoy) Operating Profit : 1,53 million yen ( ー 27.3%,Yoy) Gross ZOZOTOWN BUSINESS

More information

Operating Income. Change (%) Fiscal year ended June 30, , , ,

Operating Income. Change (%) Fiscal year ended June 30, , , , Summary Report of Consolidated Financial Results For the Fiscal Year Ended (All financial information has been prepared in accordance with accounting principles generally accepted in Japan.) Don Quijote

More information

Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2019 [Japanese GAAP] (Consolidated) August 7, 2018

Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2019 [Japanese GAAP] (Consolidated) August 7, 2018 Summary of Financial Statements [Japanese GAAP] (Consolidated) August 7, 2018 Name of listed company: SHIP HEALTHCARE HOLDINGS, INC. Shares listed on: Tokyo Stock Exchange Code: 3360 URL http://www.shiphd.co.jp/

More information

Summary of Consolidated Financial Results for the First Quarter Ended June 2011 [Japan GAAP]

Summary of Consolidated Financial Results for the First Quarter Ended June 2011 [Japan GAAP] Summary of Consolidated Financial Results for the First Quarter Ended June 2011 [Japan GAAP] August 5, 2010 Name of Company: Startia, Inc. Stock Code: 3393 Stock Exchange Listing: Tokyo Stock Exchange

More information

Business performance <FY2018>

Business performance <FY2018> Business performance Revenue and profits set record highs for the sixth consecutive year. Revenue: 390.7 billion (+28.3% YOY) Operating income: 46.0 billion (+27.5% YOY) Profit attributable to owners

More information

1.Consolidated Operating Results

1.Consolidated Operating Results 1.Consolidated Operating Results (1) Results and Forecasts for Major Financial Indicators (Billions of yen) FY2008 2008.11 YOY 2009.2 YOY 2009.11 YOY FY2009 2010.2 (Forecast) Total net sales 1,155.5 107.7%

More information

Six-month Consolidated Financial Report for the Fiscal Year Ending October 31, 2012 [Japan GAAP]

Six-month Consolidated Financial Report for the Fiscal Year Ending October 31, 2012 [Japan GAAP] Six-month Consolidated Financial Report for the Fiscal Year Ending October 31, 2012 [Japan GAAP] June 8, 2012 Listed Company Name Kanamoto Company, Ltd. Company Code Number 9678 Listing Exchanges Tokyo

More information

Net sales Operating profit Ordinary profit

Net sales Operating profit Ordinary profit Notice: This document has been translated from Japanese original for reference purpose only, without any warranty as to its accuracy or as to the completeness of the information. The Japanese original

More information

Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2018 (Japan GAAP)

Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2018 (Japan GAAP) Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2018 (Japan GAAP) Name of Listed Company: TSUMURA & CO. Exchange: Tokyo Stock Exchange Code: 4540

More information

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results (Note) This translation is prepared and provided for readers' convenience only. In the event of any discrepancy between this translated document and the original Japanese document, the original document

More information

Consolidated Financial Summary for the Third Quarter Ended September 30, 2018 (Japanese Standard)

Consolidated Financial Summary for the Third Quarter Ended September 30, 2018 (Japanese Standard) This document is a summary translation of the Japanese language original version. In the event of any discrepancy, errors and/or omissions, the Japanese language version shall prevail. Consolidated Financial

More information

Revenue and income set record highs for the fifth consecutive year. Revenue reached more than 300 billion on the 20th anniversary of the foundation.

Revenue and income set record highs for the fifth consecutive year. Revenue reached more than 300 billion on the 20th anniversary of the foundation. Revenue and income set record highs for the fifth consecutive year. Revenue reached more than 300 billion on the 20th anniversary of the foundation. Revenue: Ordinary income: Profit attributable to owners

More information

Million yen Million yen %

Million yen Million yen % Summary of Consolidated Financial Statements for the Second Quarter of the Term Ending March 31, 2019(Japan GAAP) November 6, 2018 Name of Listed Company: TSUMURA & CO. Exchange: Tokyo Stock Exchange Code:

More information

Summary of Reference data

Summary of Reference data Summary of Reference data Fiscal Year August 2017 (September 1, 2017 to August 31, 2018) (Tokyo Stock Exchange, 1st Section:3048) 1. Fiscal Year August 2017 2. Earnings Forecast for FY2018 3. Topics 4.

More information

Fully diluted net income per share

Fully diluted net income per share Disclaimer: This document is a translation of the Japanese original. The Japanese original has been disclosed in Japan in accordance with Japanese accounting standards and the Financial Instruments and

More information

Consolidated 3Q Financial Results for FY ending March 2014

Consolidated 3Q Financial Results for FY ending March 2014 1 TSE:3738 Consolidated 3Q Financial Results for FY ending March 214 February 7, 214 Disclaimer * This material contains statements about the future performance of T-Gaia, which are based on management

More information

Net sales Operating income Ordinary income

Net sales Operating income Ordinary income FOR TRANSLATION PURPOSE ONLY DISCLAIMER This English translation is only for reference purpose. When there are any discrepancies between original Japanese version and English translation version, the original

More information

Results of Operations for the Fiscal Year Ended August 2016 (FY8/16)

Results of Operations for the Fiscal Year Ended August 2016 (FY8/16) Stock code: 2157 Results of Operations for the Fiscal Year Ended August 2016 () October 13, 2016 Contents Corporate Overview 3 Organization 4 Consolidated Results of Operations 5 Financial Highlights 6

More information

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating Summary Report of Consolidated Financial Results For the Fiscal Year Ended (All financial information has been prepared in accordance with accounting principles generally accepted in Japan.) Don Quijote

More information

Annual. Saizeriya Co., Ltd. Year ended August 31, Securities code: 7581

Annual. Saizeriya Co., Ltd. Year ended August 31, Securities code: 7581 Annual Report2016 Year ended August 31, 2016 Securities code: 7581 Saizeriya Co., Ltd. Our Philosophy Our mission La Buona Tavola Our mission calls for a restaurant that brings joy and happiness to all

More information

Net sales Operating income Ordinary income. 112, , , , Three-month period ended June 30, 2016

Net sales Operating income Ordinary income. 112, , , , Three-month period ended June 30, 2016 Summary of Consolidated Financial Results for the Three-month Period Ended June 30, 2017 (Japanese accounting standards) Released August 8, 2017 Name of listed firm: Nojima Corporation Listed on the Tokyo

More information

CONSOLIDATED EARNINGS REPORT FOR THE SECOND QUARTER OF FISCAL 2013 [Japanese GAAP]

CONSOLIDATED EARNINGS REPORT FOR THE SECOND QUARTER OF FISCAL 2013 [Japanese GAAP] Member of the Financial Accounting Standards Foundation Disclaimer: This is a Japanese-English translation of the summary of financial statements of the Company produced for your convenience. Since no

More information

Financial Results. for the Year Ended February 28, 2011 (FY02/2011) AEON DELIGHT CO., LTD. Yuiken Tsutsumi, President & CEO.

Financial Results. for the Year Ended February 28, 2011 (FY02/2011) AEON DELIGHT CO., LTD. Yuiken Tsutsumi, President & CEO. Financial Results for the Year Ended February 28, 2011 (FY02/2011) AEON DELIGHT CO., LTD. Yuiken Tsutsumi, President & CEO April 15, 2011 1 Highlights in FY02/2011 1-1 2 Merger with CERTO Corporation on

More information

Summary of Reference data

Summary of Reference data Summary of Reference data Fiscal Year 2016 (September 1, 2016 to August 31, 2017) (Tokyo Stock Exchange, 1st Section:3048) 2. Earnings Forecast for FY2017 3. Topics 4. Kojima (Subsidiary) Consolidated

More information

Flash Report on the Consolidated result for the third quarter ended November 30, 2006

Flash Report on the Consolidated result for the third quarter ended November 30, 2006 Flash Report on the Consolidated result for the third quarter ended November 30, 2006 January 9, 2007 Listed Company Name: LAWSON, INC. Code No.: 2651 (URL http://www.lawson.co.jp/company/ir/index.html)

More information

Overview Total Transaction Value:67,414 million yen(+20.2%, Yoy)Operating Profit: 7,009million yen(+16.0%, Yoy) Steady growth. Total Transaction Value

Overview Total Transaction Value:67,414 million yen(+20.2%, Yoy)Operating Profit: 7,009million yen(+16.0%, Yoy) Steady growth. Total Transaction Value Overview Total Transaction Value:67,414 million yen(+20.2%, Yoy)Operating Profit: 7,009million yen(+16.0%, Yoy) Steady growth Total Transaction Value ZOZOTOWN Business Total Transaction Value 59,785 million

More information

Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the Fiscal 2012, Ending March 31, 2012(Japan GAAP) May 11, 2012

Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the Fiscal 2012, Ending March 31, 2012(Japan GAAP) May 11, 2012 Company: Sumitomo Osaka Cement Co., Ltd. Fiscal 2011 : April 1, 2010-March 31, 2011 Stock code: 5232 Fiscal 2012 : April 1, 2011-March 31, 2012 URL: http://www.soc.co.jp/ *Figures are rounded down to the

More information

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating Summary Report of Consolidated Financial Results For the Fiscal Year Ended (All financial information has been prepared in accordance with accounting principles generally accepted in Japan.) Don Quijote

More information

Consolidated Financial Results for the Three Months Ended March, (IFRS) (Q1 FY ending December 2018)

Consolidated Financial Results for the Three Months Ended March, (IFRS) (Q1 FY ending December 2018) May 15, 2018 Consolidated Financial Results for the Three Months Ended March,31 2018 (IFRS) (Q1 FY ending December 2018) Company name: NIKKISO CO., LTD. Stock exchange listening: Tokyo Stock Exchange Stock

More information

FPG / 7148 COVERAGE INITIATED ON: LAST UPDATE:

FPG / 7148 COVERAGE INITIATED ON: LAST UPDATE: COVERAGE INITIATED ON: 2016.03.18 Shared Research Inc. has produced this report by request from the company discussed in the report. The aim is to provide an owner s manual to investors. We at Shared Research

More information

Net sales Operating income Ordinary income EBITDA. 2,679 million yen (22.3%) 4,894 million yen (16.1%) June 30, 2017:

Net sales Operating income Ordinary income EBITDA. 2,679 million yen (22.3%) 4,894 million yen (16.1%) June 30, 2017: Summary of Consolidated Financial Results for the Three-month Period Ended June 30, 2018 (Japanese accounting standards) Released August 7, 2018 Name of listed firm: Nojima Corporation Listed on the Tokyo

More information

Get the most from your prescription benefit

Get the most from your prescription benefit Get the most from your prescription benefit TE Connectivity HealthFund HRA Plan Welcome to Express Scripts What s Inside Your benefit at a glance...2 Your plan s preferred medicines...2 Prior authorization...2

More information

Pharmaceutical Management Community Plans 2018

Pharmaceutical Management Community Plans 2018 Pharmaceutical Management Community Plans 2018 Customer Service: (888) 327-0671 TTY: 711 Pharmacy Administration: (810) 244-1660 Introduction Pharmaceutical management promotes the use of the most clinically

More information

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating Summary Report of Consolidated Financial Results For the Fiscal Year Ended (All financial information has been prepared in accordance with accounting principles generally accepted in Japan.) Don Quijote

More information

Saizeriya Co., Ltd. Annual Report. Year Ended August 31, 2013

Saizeriya Co., Ltd. Annual Report. Year Ended August 31, 2013 Saizeriya Co., Ltd. Annual Report 2013 Year Ended August 31, 2013 Philosophy & Corporate Profile Working to deliver high-value meals every day Since its founding, Saizeriya has worked to provide healthy,

More information

Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the First Half of Fiscal 2019, Ending March 31, 2019 (Japan GAAP)

Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the First Half of Fiscal 2019, Ending March 31, 2019 (Japan GAAP) Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the First Half of Fiscal 2019, Ending March 31, 2019 (Japan GAAP) Company: Sumitomo Osaka Cement Co., Ltd. Fiscal 2018 :

More information

Details of financial results of FY2017 are as follows.

Details of financial results of FY2017 are as follows. Details of financial results of are as follows. (Unit: million yen) FY2016 YoY Against Guidance Total Transaction Value 212,090 (100.0%) 270,543 (100.0%) 27.6% 0.2% Net Sales 76,393 (36.0%) 98,432 (36.4%)

More information

Summary of Consolidated Financial Results for the First Half Ended September 30, 2008

Summary of Consolidated Financial Results for the First Half Ended September 30, 2008 Head Office : 8-1 Nihonbashi Odenmacho, Chuo-ku, Tokyo, Japan Code No. : 7537 (URL http://www.marubun.co.jp) Contact : Corporate Planning Dept., Phone +81-3-3639-3010, Fax +81-3-5644-7693 November 7, 2008

More information

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019 [Japanese GAAP] August 13, 2018

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019 [Japanese GAAP] August 13, 2018 Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019 [Japanese GAAP] August 13, 2018 Company name: Striders Corporation Listing: Tokyo Stock Exchange

More information

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2015 (FY3/15) (Three Months Ended June 30, 2014)

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2015 (FY3/15) (Three Months Ended June 30, 2014) August 8, 2014 Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2015 (FY3/15) (Three Months Ended June 30, 2014) [Japanese GAAP] Company name: Sanyo Homes

More information

We encourage readers to review our complete legal statement on Disclaimer page.

We encourage readers to review our complete legal statement on Disclaimer page. Company Research and Analysis Report FISCO Ltd. http://www.fisco.co.jp 伪伪 Completely absorbed the impact of the revisions to the dispensing fees and achieved a V-shaped recovery after results bottomed-out

More information

Consolidated Financial Results for the Six Months Ended June, (IFRS) (Q2 FY ending December 2018)

Consolidated Financial Results for the Six Months Ended June, (IFRS) (Q2 FY ending December 2018) August 10, 2018 Consolidated Financial Results for the Six Months Ended June,30 2018 (IFRS) (Q2 FY ending December 2018) Company name: NIKKISO CO., LTD. Stock exchange listening: Tokyo Stock Exchange Stock

More information

FY3/2018 Results. (Tokyo Stock Exchange / Nagoya Stock Exchange: 8593) May 15, 2018 Mitsubishi UFJ Lease & Finance Company Limited

FY3/2018 Results. (Tokyo Stock Exchange / Nagoya Stock Exchange: 8593) May 15, 2018 Mitsubishi UFJ Lease & Finance Company Limited FY3/2018 Results (Tokyo Stock Exchange / Nagoya Stock Exchange: 8593) May 15, 2018 Mitsubishi UFJ Lease & Finance Company Limited Index Ⅰ FY3/2018 Results Ⅱ Ⅲ Ⅳ Forecast for FY3/2019 Progress of Medium-Term

More information

Moving from Pediatric to Adult Care: Prescription Medicines, Supplies, and Equipment

Moving from Pediatric to Adult Care: Prescription Medicines, Supplies, and Equipment Moving from Pediatric to Adult Care: Prescription Medicines, Supplies, and Equipment To take care of your own health, you need to know how to fill prescriptions. Most prescriptions for medicines can be

More information

NIHON KOHDEN CORPORATION (6849)

NIHON KOHDEN CORPORATION (6849) These documents have been translated from Japanese originals for reference purposes only. In the event of any discrepancy between these translated documents and the Japanese originals, the originals shall

More information

Net Income per Share (Yen) (2) Financial Position (Millions of yen, except per-share data) Shareholders Equity

Net Income per Share (Yen) (2) Financial Position (Millions of yen, except per-share data) Shareholders Equity Summary Report of Consolidated Financial Results For the (All financial information has been prepared in accordance with accounting principles generally accepted in Japan.) Don Quijote Co., Ltd. Securities

More information

Net sales Operating income Ordinary income EBITDA. 16,152 million yen (9.5%)

Net sales Operating income Ordinary income EBITDA. 16,152 million yen (9.5%) Summary of Consolidated Financial Results for the Nine-month Period Ended December 31, 2018 (Japanese accounting standards) Released January 31, 2019 Name of listed firm: Nojima Corporation Listed on the

More information

Asahi Group Holdings, Ltd.

Asahi Group Holdings, Ltd. Asahi Group Holdings, Ltd. FY2013 1Q Financial Results NOTE: All information has been prepared in accordance with generally accepted accounting principles in Japan. Amounts shown in this accounting report

More information

Flash Report for the Fiscal Year ended December 31, 2013 [Japan GAAP] (on a consolidated basis)

Flash Report for the Fiscal Year ended December 31, 2013 [Japan GAAP] (on a consolidated basis) Flash Report for the Fiscal Year ended December 31, [Japan GAAP] (on a consolidated basis) January 31, 2014 Company Name: OPT, Inc. Stock exchange listing: Tokyo Stock Code: 2389 URL http://www.opt.ne.jp/

More information

FACTBOOK. ABC-MART, INC. For the fiscal year ended February 28, Contents. Securities Code: 2670 / TSE 1st Section

FACTBOOK. ABC-MART, INC. For the fiscal year ended February 28, Contents. Securities Code: 2670 / TSE 1st Section FACTBOOK ABC-MART, INC. For the fiscal year ended February 28, 217 Contents Corporate Profile 1-4 Consolidated Balance Sheet 5-6 Consolidated Statement of Income 7-8 Consolidated Statement of Cash Flows

More information

Meganesuper On December 15, 2016, Meganesuper announced earnings results for 1H FY04/17. FY04/16. Shared Research Report 1/7

Meganesuper On December 15, 2016, Meganesuper announced earnings results for 1H FY04/17. FY04/16. Shared Research Report 1/7 Shared esearch eport Meganesuper 3318 This PDF document is an updated note on the company. A comprehensive version of the report on the company, including this latest update, is available on our website

More information

Summary of Consolidated Financial Results for the 9 Months Ended November 30, 2016 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the 9 Months Ended November 30, 2016 (Based on Japanese GAAP) Translation tice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the

More information

FY May-2006, 3Q Result Presentation. April

FY May-2006, 3Q Result Presentation. April FY May-2006, 3Q Result Presentation April 11 2006 http://www.kobetsu.co.jp/ 3Q of FY May-2006 Summary million yen Sales Recurring Profit Net Profit 13,000 12,000 11,000 10,532 12,241 1,900 1,700 1,100

More information

Summary of Consolidated Financial Results of Fiscal 2014

Summary of Consolidated Financial Results of Fiscal 2014 Summary of Consolidated Financial Results of May 9, 2014 Name of Listed Company: TOHO HOLDINGS CO., LTD. Listed: Tokyo Stock Exchange Securities Code Number: 8129 URL: http://www.tohohd.co.jp Corporate

More information

Consolidated Financial Results for the Fiscal Year Ended March 31, 2016 [IFRS] (Abridged)

Consolidated Financial Results for the Fiscal Year Ended March 31, 2016 [IFRS] (Abridged) Consolidated Financial Results for the Fiscal Year Ended [IFRS] (Abridged) Apr 26, 2016 Listed Company: M3, Inc. Listed Stock Exchange: Tokyo Securities Code: 2413 URL: http://corporate.m3.com/ Representative:

More information

Consolidated Financial Results for the First Quarter of Fiscal Year 2018

Consolidated Financial Results for the First Quarter of Fiscal Year 2018 Consolidated Financial Results for the First Quarter of Fiscal Year Company name: DISCO Corporation Stock code number: 6146 (Tokyo Stock Exchange 1st Section) URL: http://www.disco.co.jp Telephone number:

More information

Net sales Operating income Ordinary income EBITDA. 7,727 million yen (72.9%) 11,559 million yen (35.5%)

Net sales Operating income Ordinary income EBITDA. 7,727 million yen (72.9%) 11,559 million yen (35.5%) Summary of Consolidated Financial Results for the Six-month Period Ended September 30, 2018 (Japanese accounting standards) Released October 30, 2018 Name of listed firm: Nojima Corporation Listed on the

More information

(URL:

(URL: QUARTERLY BUSINESS REPORT for the 1 st quarter of the year ending March 2006 (Consolidated) August 12, 2005 Listed company name Nichii Gakkan Company (URL: http://www.nichiigakkan.co.jp) Representative

More information

Consolidated Financial Results for the Nine Months Ended September 30, 2018 (IFRS) (Q3 FY ending December 2018)

Consolidated Financial Results for the Nine Months Ended September 30, 2018 (IFRS) (Q3 FY ending December 2018) November 13, 2018 Consolidated Financial Results for the Nine Months Ended September 30, 2018 (IFRS) (Q3 FY ending December 2018) Company name: NIKKISO CO., LTD. Stock exchange listening: Tokyo Stock Exchange

More information

Profitability. Topics

Profitability. Topics 1 Overview Total Transaction Value:129.0 billion yen(+12.5%, Yoy)Operating Profit: 15.0 billion yen(+21.8%, Yoy) We have achieved : 97% for Total Transaction Value, 110% for Operating Profit, of our original

More information

Consolidated Financial Results for the Second Quarter of Fiscal Year 2018

Consolidated Financial Results for the Second Quarter of Fiscal Year 2018 October 30, 2018 Consolidated Financial Results for the Second Quarter of Fiscal Year 2018 Company name: DISCO Corporation Stock code number: 6146 (Tokyo Stock Exchange 1st Section) URL: http://www.disco.co.jp

More information

Net sales Operating income Ordinary income. Six months ended September 30, 2015: 4,563 million yen (204.2%)

Net sales Operating income Ordinary income. Six months ended September 30, 2015: 4,563 million yen (204.2%) Summary of Consolidated Financial Results for the Six-month Period Ended September 30, 2015 (Japanese accounting standards) Released November 4, 2015 Name of listed firm: Nojima Corporation Listed on the

More information

Summary of Settlement of Consolidated Accounts for the First Quarter of the Fiscal Year ending March 31, 2013 Japanese Standards (Consolidated)

Summary of Settlement of Consolidated Accounts for the First Quarter of the Fiscal Year ending March 31, 2013 Japanese Standards (Consolidated) Japanese Standards (Consolidated) Isetan Mitsukoshi Holdings Ltd. August 10, 2012 Securities code: 3099 (Listed on the First Section of Tokyo Stock Exchange and Fukuoka Stock Exchange) (URL: http://www.imhds.co.jp)

More information

NeedyMeds

NeedyMeds NeedyMeds Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need. REMEMBER - Send your

More information